Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Biol Psychiatry. Author manuscript; available in PMC 2010 July 1.
Published in final edited form as:
PMCID: PMC2696581

Increased anxiety during anticipation of unpredictable aversive stimuli in posttraumatic stress disorder but not in generalized anxiety disorder



Uncontrollability and unpredictability are key concepts related to re-experiencing, avoidance and hypervigilance symptoms of posttraumatic stress disorder (PTSD). However, little is known about the differential sensitivity of PTSD individuals to unpredictable stressors, relative to either healthy individuals or individuals with other anxiety disorders. This study tested the hypothesis that elevated anxious reactivity, specifically for unpredictable aversive events, is a psychophysiological correlate of PTSD.


Sixteen patients with PTSD (34.5 ± 12.4 years) were compared to 18 patients with GAD (34.0 ± 10.5 years) and 34 healthy controls (30.2 ± 8.5 years). Participants were exposed to three conditions: one in which predictable aversive stimuli were signaled by a cue, a second in which aversive stimuli were administered unpredictably, and a third in which no aversive stimuli were anticipated. Startle magnitude was used to assess anxious responses to the threat cue and to contexts associated with each condition.


PTSD and GAD patients showed normative enhancement of fear to the predictable threat cue, but the PTSD group displayed elevated anxiety during the unpredictable condition compared to participants with GAD and healthy controls.


Anxious reactivity to unpredictable aversive events was heightened in PTSD, but not in GAD and healthy subjects. Prior works also found signs of increased reactivity to unpredictable threat in panic disorder (PD), suggesting that PTSD and PD may involve shared vulnerability. As such, the current results inform understandings of classification, pathophysiology and psychopharmacology of anxiety disorders, generally, and PTSD and panic disorder specifically.

Keywords: PTSD, generalized anxiety disorder, predictability, threat, fear-potentiated startle


Startle reflex studies in rodents dissociate neural systems underlying phasic responses to predictable threats from those mediating tonic responses to unpredictable threats (1, 2). While the central nucleus of the amygdala is implicated in the former class of response, the bed nucleus of the stria terminalis (BNST) — and its modulation by corticotrophin-releasing hormone (CRH) —is involved in the latter. Davis and collaborators labeled the phasic response to predictable threat “fear” and the tonic response to unpredictable threat “anxiety” 1.

This dissociation between “fear” and “anxiety” may relate to current anxiety-disorder classification, linking specific anxiety disorders to dysfunction in distinct brain regions. Relating specific anxiety disorders to patterns of reactivity found in research with rodents might elucidate pathophysiological mechanisms and provide targets for psychopharmacological treatments.

We recently reported that patients with panic disorder (PD) were overly sensitive to unpredictable threats 3, while showing a normal response to predictable (signaled) threats. This suggests that PD involves normal “fear” but enhanced “anxiety”. Given that vulnerability to unpredictability is seen in several anxiety disorders 46, it is possible that this profile of enhanced “anxiety” may occur in several conditions. The present study extends this line of research to two patient groups, posttraumatic stress disorder (PTSD) and generalized anxiety disorder (GAD). Based on converging evidence from different areas, we hypothesized that PTSD would show exaggerated responses to unpredictable threat. First, theoretical accounts of PTSD indicate that the quality of unpredictability in the aversive experience is crucial to the development and maintenance of PTSD symptoms 5. These theories are based on the observation that animal exposed to unpredictable but not to predictable threats show behaviors reminiscent of PTSD in humans 7, 8. Second, empirical evidence suggests heightened reactivity to uncertainty in PTSD. We have reported a proneness of PTSD individuals to show exaggerated ‘baseline’ startle in threatening contexts 9, 10. For example, baseline startle in Vietnam veterans with PTSD is normal in innocuous laboratory setting (with no explicitly threatening stimuli) but it is elevated during experiments associated with later administration of shocks 9. This contextual anxiety possibly reflects anticipatory anxiety about the upcoming stressful test. Of note, PTSD individuals do not show increased fear-potentiated startle to an imminent shock signaled by a threat cue 9, 11. Interestingly, prior work in PD also demonstrates similar signs of contextually-modulated threat hypersensitivity, occurring in tandem with normal responding to an imminently-signaled shock 12. Finally, consistent with these psychophysiology data, PTSD and PD also share common phenomenology including the unpredictable and uncontrollable nature of the stress and enhanced anxiety sensitivity 13. PTSD is precipitated by uncontrollable and unpredictable traumatic events, which result in intrusive recollections of the trauma with associated hyper-arousal and anxiety 14. Panic disorder (PD) is also characterized by brief and intermittent unpredictable and uncontrollable aversive episodes (panic attacks) interspersed with anticipated anxiety of these aversive events. Furthermore, PD and PTSD share several biological abnormalities including increased susceptibility to panic attacks with yohimbine administration 15, 16.

Excessive and uncontrollable worry about a number of events or activities is a fundamental symptom of GAD 17, 18. Because intolerance of uncertainty is key to pathological worry and GAD 19, one might also expect enhanced reactivity to unpredictable threat in GAD. However, the nature of worry and its physiological manifestations are unclear. GAD is usually associated with increased muscle tension, not autonomic arousal. Work on physiological reactivity in GAD finds minimal evidence of hyper-arousal and some evidence of reduced arousal 20. Nevertheless, because this is the first study of unpredictable threat in GAD, only provisional hypotheses are possible.

The present study examined responses to predictable and unpredictable aversive events using the same well-validated startle paradigm implemented to test patients with PD 3. Startle and subjective measures of anxiety were assessed across three conditions: 1) a neutral (N) condition during which no unpleasant event was delivered, 2) a predictable (P) condition in which unpleasant events could occur only during a discrete ‘threat’ cue, and 3) an unpredictable (U) condition during which unpleasant events could occur at any time. This paradigm provides measures of fear (e.g., fear-potentiated startle) associated with the threat cue in the P condition and of anxiety (e.g., context-potentiated startle) in the N, P, and U contexts (no-cue periods). We hypothesized that PTSD would be associated with normal startle potentiation in response to threat cues (P), but enhanced potentiation during the U condition.



Sixteen medication-free PTSD patients (9 women and 7 men; mean ± SD age, 34.5 ± 12.4 years), 18 GAD patients (14 women and 4 men; mean ± SD age, 34.0 ± 10.5 years), and 34 healthy controls (25 women and 9 men; mean ± SD age, 30.2 ± 8.5 years) participated in the study. Mean age did not significantly differ across groups (F[1,62]=.9, ns). The patients met DSM-IV criteria for PTSD or GAD as assessed by the Structural Clinical Interview for DSM-IV Axis I disorders (SCID) 21. Participants with PTSD were included if the severity of the PTSD as measured by the Clinician-Administered PTSD Scale (CAPS; 22) was ≥ 50. The PTSD mean CAPS scores was 72.9 (SD=4.2). Comorbidities among PTSD patients included current major depressive disorder (n=4), past major depressive disorder (n=2), and past substance abuse (n=2). Comorbidities among GAD patients included social anxiety disorder (n=3), current major depressive disorder (n=1), past substance abuse (n=1), and specific phobia (n=1). Healthy controls had no current or past psychiatric diagnosis according to the SCID and were physically healthy. All subjects were free of drugs as per a urine screen. After description of the study was given to subjects, written informed consent was obtained.

Stimuli and Physiological Responses

Stimulation and recording were controlled by a commercial system (Contact Precision Instruments, London, England). The eyeblink reflex was recorded with electrodes under the left eye. Amplifier bandwidth was set to 30–500 Hz. Startle was elicited with an air-puff to the forehead, which gives similar results as a white noise 23, using a 40-ms, 7-psi puff delivered through a poly-ethylene tube (2.0-foot-length, 1/8-inch-diameter) (see 23 for additional information). Unpleasant stimuli consisted of four different 3-sec duration, 95dB aversive sounds: 1) white-noise, 2) a 2 kHz-tone, 3) smoke alarm and 4) human female scream (the human scream was accompanied by a briefly-presented picture of a fearful woman).


The procedure was the same as in a recent study in PD 3. Participants were given explicit instructions regarding the conditions under which unpleasant stimuli were administered. The threat experiment consisted of three 150-sec conditions (Fig. 1): 1) no-aversive-event (N); 2) predictable-aversive-event (P); and 3) unpredictable-aversive-event (U). In each 150-sec condition, a 10-sec cue was presented four times. The cues were different colored geometric shapes for each of the different conditions (e.g., blue square for N, red circle for P). The cues signaled the possibility of receiving an aversive stimulus in the P condition only, but had no signal value in the N and U conditions. During the experiment, instructions were continuously displayed showing: “no unpleasant event” (N), “unpleasant event only during shape” (P), or “unpleasant event at any time” (U).

Figure 1
Schematic of the experiment. Subjects were presented with three neutral (N), two predictable (P), and two unpredictable (U) contexts (order U N P N P N U as shown or P N U N U N P). Each N, P, and U condition contained four 8-s duration cues. In the P ...

The experiment started with the delivery of six pre-test startle stimuli to habituate initial startle reactivity (results not shown). Fifteen seconds after the last of these startle stimuli, the fear-potentiated startle experiment started. It consisted of three N, two P, and two U conditions in one of the following two orders: P N U N U N P or U N P N P N U. Half the participants in each group received the former order and the other half of participants received the latter order. Two aversive events were administered in each individual P and U condition for a total of eight aversive stimuli. The aversive events were delivered at cue offset in the P condition and in the absence of a cue in the U condition. In each condition (i.e, N, P, U), six tactile startle stimuli were delivered, three during cue-free periods and one during three of the four cues, 5–7 sec following cue onset. The mean inter-startle interval during the experiment was 21 s (range 18–25 s). In addition, no startle stimulus was delivered less than 8 sec after an aversive stimulus in order to avoid potential short-term sensitization of startle.

After completion of the test, subjects retrospectively rated their anxiety level in the presence and absence of the cue in each condition (N, P, U) on a Likert scale ranging from 0 (not at all anxious) to 10 (extremely anxious). They also indicated which of the two aversive conditions, predictable and unpredictable, they disliked most.

Data Analysis

Peak blink amplitude was determined in the 20–100-ms time frame following stimulus onset relative to baseline taken 50 ms preceding stimulus onset. Eyeblink magnitudes were standardized using within-subjects T scores ([Z scores × 10] + 50). Results with T scores and raw scores were similar. To increase comparability of our current results with our previous study in PD 3, we present results only with the T scores, except when T scores and raw scores differed. (Mean raw scores are shown in Table 1.) Startle magnitudes and subjective ratings were averaged across conditions, separately for cues and cue-free periods. Fear was operationally defined as the increase in startle (fear-potentiated startle) or in subjective rating during the cue. Fear-reactivity to the cue was calculated as the difference in startle magnitude or subjective ratings between cue and cue-free periods in each condition. Anxiety was operationally defined as the increase in startle or in subjective anxiety during the cue-free period from the N condition to the P and U conditions. Because of our a priori hypothesis, we conducted two separate ANOVAs, one for the threat cue (fear) and the other for the cue-free period (anxiety), as done in our prior studies 24, 25. The startle and subjective fear scores (difference scores between cue and cue-free period) were entered in separate Group (controls, patients) × Condition (N, P, U) × Sex (males, females) ANOVAs. We predicted a main effect of condition due to greater startle and subjective rating in the P condition, compared to the N and U conditions. We did not expect a significant Group × Condition interaction, as we hypothesized no difference in response to the cue among groups. The cue-free period startle and subjective rating data were entered in a Group (controls, patients) × Condition (N, P, U) × Sex (females, males) ANOVA. We predicted that the PTSD group, but not the control group, would show greater responses in the U compared to the P condition, resulting in a linear trend across the N, P, and U conditions in the PTSD group only and a significant linear Group × Condition interaction.

Alpha was set at .05 for all statistical tests. Greenhouse-Geisser corrections (GG-ε) were used for main effects and interactions involving factors with more than two levels.


Startle magnitude

Startle data (raw and T scores) are presented in Table 1. Overall startle magnitudes (raw scores) appear larger in the PTSD group compared to the other groups but this effect was not significant (omnibus ANOVA (Group (3) × Condition (2) × (Cue (cue, no cue): F[2,62]=1.6, ns).

Fear-potentiated startle

Fear-potentiated startle to the cues differed significantly among conditions (Condition; F[2,122]=8.3, p=.001, GGε=.89), due to larger potentiated startle in the P and U conditions, compared to N condition (t[67]=5.6, p<.0009 and t[67] =8.2, p<.0001, respectively). Fear-potentiated startle was larger in the P condition compared to the U condition (t[67]=2.2, p=.03). As hypothesized, the magnitude of fear-potentiated startle did not differ between groups (Group × Condition; F[2,126]=.2, ns) even in an analysis restricted to P (F[2,62]=.4, ns). There was no sex difference in any effects.

Context-potentiated startle

Context-potentiated startle, reflecting the sustained change in startle associated with each condition (see Methods), was evaluated using startle magnitudes during cue-free periods (Table 1). Startle reactivity across conditions differed among the three groups (Condition × Group: F[4,122]=2.5, p<.04, GG-ε=.99). Both the healthy and GAD groups showed the largest response in the P condition, compared to the N and U conditions. The PTSD group, in contrast, showed the largest startle in the U condition (Fig. 2). Specifically, startle magnitudes among PTSD patients during cue-free periods increased progressively from N, to P, to U (linear trend: F[1,14]=17.5, p<.001) showing significantly larger startle magnitude in U compared to N (F[1,14]=8.4, p<.01), a pattern contrasting that found in the control and GAD groups, where startle magnitude was the largest in P, though this effect reached significance only in the former group (quadratic trend over N, P, U; F[1,32]=8.0, p<.01). Follow-up analyses comparing the PTSD group with the control group show significant Condition × Group interactions and Condition × Group linear trend (F[2,92]=6.9, p<.002, GG-ε=.93 and F[1,46]=9.3, p<.004, respectively). Similar results were found when comparing the PTSD and GAD groupd (F[2,60]=3.5, p<.04 (F[2,60]=2.5, p<.11 with the raw scores), GG-ε=.95 and F[1,30]=4.4, p<.04 (F[1,30]=2.2, p<.14 with raw scores), respectively), but not when comparing the control and GAD groups (F[2,96]=.1, ns, GG-ε=.98) (see also Fig 2 legend). Sex did not influence the results.

Figure 2
Startle magnitudes in the cue-free periods in the no aversive event (N), predictable (P), and unpredictable (U) conditions among the control, PTSD, and PD groups.


Subjective ratings are shown in Table 1. One subject in each patient group had missing subjective ratings.

Subjective rating during the cue

As expected, subjective rating to cues differed significantly across conditions (F[2,120]=33.3, p<.0009, GG-ε=.86), due to greater subjective anxiety to the cue in the P condition compared to the N condition (t[66]=8.2, p<.0009) and U (t[66]=7.9, p<.0009). Similar to the startle data, the three groups did not differ in subjective rating to the cues (Group main: F[2,60]=.2, ns; Cue-by-Group interaction: F[4,120]=.6, ns). An analysis restricted to the P condition also revealed no significant difference in subjective anxiety to the threat cue.

Subjective rating during each context

Overall, subjective anxiety during cue-free periods differed among groups (F[2,60]=4.5, p<.01), due to greater subjective anxiety in the PTSD compared to the control group (F[1,45]=9.1, p<.004). The GAD group also tended to have higher overall ratings of subjective anxiety but ratings in GAD differed from neither the healthy (F[1,44]=2.4, p=.12) nor the PTSD (F[1,28]=.7, ns) groups. Overall subjective anxiety was also higher in females compared to males (F[2,60]=9.4, p<.003), but this effect did not differ among groups. Unlike the startle data, subjective anxiety did not differ among the three groups across contexts (F[4,110]=.4, ns).

Condition subjects disliked

All three groups disliked the U condition more than the P condition and this stronger dislike for the U condition was comparable (χ2=1.60, ns) across the three groups (control: 79%; PTSD: 94%; GAD; 83%).


As hypothesized, PTSD patients compared to GAD patients and healthy controls displayed heightened anxiety during periods of unpredictable, but not predictable, threat. Specifically, startle potentiation during the no-cue period of the unpredictable versus neutral condition—reflecting heightened contextual anxiety—was observed only in the PTSD group. In contrast, fear-potentiated startle to the threat cue predictably signaling the aversive events was increased to the same extent in the three groups.

The results are consistent with previous startle studies showing normal fear-potentiated startle to an imminent threat in PTSD, together with heightened startle potentiation to more distal or uncertain threat 9, 26 (see Introduction). For example, Pole et al reported increased anxiety in police officers with PTSD under “low threat” after they were instructed that they would be shocked later in the study, but not under “high’ threat signaling an imminent shock 27. These results are consistent with the view that PTSD individuals are overly sensitive to unpredictability because distal stressors may introduce uncertainty. Alternatively, PTSD individuals may be overly sensitive to stressors in general, but greater control-patient differences emerge more readily under low threat levels (See 28). This latter interpretation is unlikely given the different pattern of startle potentiation to the different contexts across groups (i.e., greater contextual anxiety in P in the controls and in U in the PTSD patients). These results suggest that compared to healthy controls, PTSD individuals do not show a general increase in anxiety, but a specific sensitivity to unpredictable aversive stimuli.

This sensitivity to unpredictability is only partly specific to PTSD. While the current study differentiated PTSD from GAD, prior work found heightened anxiety to unpredictability in PD 29. PTSD and PD share several common clinical features, in that both syndromes are associated with paroxysms of subjective distress and associated physiological symptoms which might be alternatively conceptualized as either flashbacks or panic attacks 30. Further, PTSD and PD frequently co-occur in clinical- and general-population samples 3032.

Heightened contextual anxiety during unpredictable aversive events may be a shared clinical phenotype of subtypes of anxiety disorders characterized by intermittent, unpredictable, aversive experiences, anticipatory anxiety, and hypervigilance. If so, then why was anxiety in the U context not elevated in GAD? One possibility is that GAD patients are also sensitive to unpredictability but their threshold for abnormal responding is higher than in the PTSD group. This hypothesis could be tested using more noxious stimuli such as shocks. Another possibility is that the nature of anxiety is qualitatively different in GAD relative to PTSD or PD. The hallmark of GAD is worry. Some suggest that worry is not synonymous with anticipatory anxiety 34 but rather reflect verbally-mediated coping mechanism that serves to distract from an impending threat 35. GAD is characterized by reduced rather than increased physiological arousal during stressors 20. In this respect, and consistent with the present study, GAD differs from other anxiety disorders. Both PTSD and panic disorder are characterized by paroxysms of crescendo anxiety, which occur as part of panic attacks in panic disorder and flashbacks in PTSD. GAD, in contrast, involves no such crescendo episodes.

The lack of startle potentiation in the unpredictable condition in the control and GAD groups is in line with our previous reports 36, 37. On the one hand, anticipation of aversive events signaled by a cue induces robust fear-potentiated startle regardless of whether the aversive event is a shock or less noxious stimuli such as those used in the present study 37, 38. On the other hand, contextual-potentiated startle in an unpredictable condition is affected by the degree of stimulus aversiveness, with more noxious stimuli generating greater contextual anxiety 3, 37. We have repeatedly found a linear increase in startle magnitude from N to P to U with shocks, but not when using strong blasts of air to the neck or a collection of unpleasant sounds and visual stimuli such as those used in the present study 3, 37. Thus, unpredictability increases anxiety provided sufficiently aversive stimuli are used (but see 39), raising the possibility that PTSD patients have a reduced threshold for anxious reactivity to unpredictability.

The subjective ratings did not closely match the startle data. In work using methods similar to those employed here, dissociation between physiological measures and subjective reports is the rule rather than the exception 3, 25, 40, 41. Two related explanations may account for this consistent trend. First, in the current study, as in many previous studies, startle probed aversive states on line, whereas the subjective ratings were made retrospectively at the end of the experiment. The delay in rating may have obscured subtle differences between contexts. Second, startle and subjective ratings may measure distinct aspects of anxiety. Startle may represent a more direct index of a primitive defensive system (e.g. amygdala), whereas subjective reports may represent more elaborative cognitive processes dependent on complex, cortically-based categorization. There is considerable evidence that the amygdala can be activated in the absence of subjective feelings of anxiety or conscious awareness of the threat stimulus ((for a review see 42). For example, during aversive conditioning startle can be increased during the conditioned stimulus in subjects unaware of the contingency between the conditioned stimulus and the unconditioned stimulus 43. Conversely, data from patients with amygdala lesions display intact subjective-state rating behavior 44. This supports the distinction between amygdala-mediated processes, such as startle potentiation, and subjective-state ratings. It is nevertheless noteworthy that overall subjective anxiety was the highest among the PTSD subjects. This result suggests enhanced contextual anxiety. Alternatively, the PTSD group may suffer from a general bias toward greater subjective ratings. However, this is unlikely because there was no group difference in ratings to the threat cue.

A crucial question is whether the sensitivity to unpredictability is a pre-existing vulnerability factor for PTSD or a sequel of trauma exposure. Emerging data in PTSD and in high-risk groups points to the former interpretation. In a prospective study in police officer cadets, Pole et al reported that contextual anxiety evoked by distal threat predicted PTSD symptom severity following a one-year exposure to police-related trauma 45. The possibility that proneness to contextual anxiety is an endophenotype for anxiety disorders is also suggested by findings of heightened contextual anxiety in non-affected children of parents with an anxiety disorder 46, 47 and individuals with high levels of neuroticism 48.

The present finding may have implications for identifying underlying neural abnormalities in PTSD as well as for pathophysiology-based psychopharmacological treatments. Rodent studies have identified two separate neural systems for phasic fear and more sustained anxiety, the latter being mediated by the BNST in concert with CRF 1. The BNST is also involved in the long-lasting anxiety states evoked by uncontrollable stressors 49. Neuroimaging studies have begun to delineate the brain circuit involved in sustained anxiety to unpredictable stressors in humans. Unpredictable shock activates a network of regions, including the amygdala, hippocampus, and ventromedial prefrontal cortex 50, 51. BNST activation has been reported during anticipation of speech in speech phobics (52). Preclinical research points to a crucial role for CRF in animal models of stress disorders, particularly PTSD 53, 54. There is substantial evidence to suggest that CRF receptors mediate the sustained potentiation of startle to unpredictable threat in rodents 1. This observation has prompted the exploration of CRF receptor antagonists as novel anxiolytics in humans 53, 54. Continuous sampling and single-point assessment of CSF in patients with combat-related PTSD confirm elevated CRF concentrations 55, 56. Whether a CRF antagonist would also suppress enhanced context-potentiated startle in humans is currently unknown, but it is likely that CRH antagonists would be effective in treating anxiety disorders associated with heightened reactivity to contextual anxiety. Accordingly, we predict that CRH antagonists may alleviate symptoms of anxiety in PTSD and PD, but not in GAD.

Results must be considered in light of study limitations. One limitation was the unequal number of males compared to females in each group, especially in the GAD group. However, a reanalysis of the data only in the females confirmed the present findings. We found significant linear increases in startle from the N to P to U condition in the males (43.5, 45.9, 49.0, respectively; F[1,6]=9.1, p<.02) and in the females (41.3, 43.3, 48.6, respectively; F[1,8]=10.2, p<.01) with PTSD. A second limitation is the absence of a trauma control group. Hence, the present finding may be due to the effect of trauma rather than PTSD per se. However, the prospective observation that symptoms of heightened anxiety to distal threat characterize only trauma exposed police officer cadets who later develop PTSD argues against this interpretation 45. Finally, four of the PTSD patients had current comorbid depression. It is unlikely that depression mediated the contextual effect as depression has been associated with reduced rather than enhanced startle 57. A reanalysis excluding PTSD patients with current depression confirmed the results. There was significant linear increases in startle from the N to P to U condition in the remaining PTSD patients (43.0, 44.9, 49.0, respectively; F[1,11]=12.2, p<.005), who showed a significantly different pattern of response compared to the controls (Condition × Group linear trend (F[1,42]=6.6, p<.01).

To summarize, unpredictable aversive events induced heightened anxiety in PTSD, but not in GAD. Basic research in animals 1 and neuroimaging studies in humans 50 are helping to delineate psychopharmacological mechanisms and neural circuits involved in human fear and anxiety. The current experimental paradigm represents a valuable tool that helps translate these separate neural circuits to research in anxiety disorders. Future neuroimaging studies in patients with anxiety disorders may provide important clues as to the neural mechanisms of fear and anxiety and may help design novel pathophysiology-based psychopharmacological treatments.


Financial support of this study was provided by the Intramural Research Program of the National Institute of Mental Health. The authors report no competing interest.



The author(s) declare that, except for income received from the primary employer, no financial support or compensation has been received from any individual or corporate entity over the past 3 years for research or professional service and there are no personal financial holdings that could be perceived as constituting a potential conflict of interest. Dr Pine has received compensation for activities related to teaching, editing, and clinical care that pose no conflicts of interest.


1. Walker DL, Toufexis DJ, Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol. 2003;463:199–216. [PubMed]
2. Grillon C. Models and mechanisms of anxiety: evidence from startle studies. Psychopharmacology. 2008;199:421–37. [PMC free article] [PubMed]
3. Grillon C, Lissek S, Rabin S, McDowell D, Dvir S, Pine DS. Increased anxiety during anticipation of unpredictable but not predictable aversive stimuli as a psychophysiologic marker of panic disorder. Am J Psychiatry. 2008;165:898–904. [PMC free article] [PubMed]
4. Mineka S, Zinbarg R. A contemporary learning theory perspective on the etiology of anxiety disorders: it’s not what you thought it was. The American psychologist. 2006;61:10–26. [PubMed]
5. Foa EB, Zinbarg R, Rothbaum BO. Uncontrollability and unpredictability in post-traumatic stress disorder: an animal model. Psychol Bull. 1992;112(2):218–238. [PubMed]
6. Dugas MJ, Gagnon F, Ladouceur R, Freeston MH. Generalized anxiety disorder: a preliminary test of a conceptual model. Behav Res Ther. 1998;36:215–26. [PubMed]
7. Mineka S, Kihlstrom JF. Unpredictable and uncontrollable events: A new perspective on experimental neurosis. J Abnorm Psychol. 1978;87:256–271. [PubMed]
8. Masserman JH. Behavior and Neurosis: An experimental psychoanalytic approach to psychobiologic principle. Chicago: Chicago University Press; 1943.
9. Grillon C, Morgan CA, Davis M, Southwick SM. Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder. Biological Psychiatry. 1998;44:1027–1036. [PubMed]
10. Morgan CA, III, Grillon C, Southwick SM, Davis M, Charney DS. Fear-potentiated startle in posttraumatic stress disorder. Biological Psychiatry. 1995;38:378–385. [PubMed]
11. Grillon C, Morgan CA. Fear-potentiated startle conditioning to explicit and contextual cues in Gulf war veterans with posttraumatic stress disorder. Journal of Abnormal Psychology. 1999;108:134–142. [PubMed]
12. Grillon C, Ameli R, Goddard A, Woods S, Davis M. Baseline and fear-potentiated startle in panic disorder patients. Biological Psychiatry. 1994;35:431–439. [PubMed]
13. Asmundson GJ, Stapleton JA. Associations between dimensions of anxiety sensitivity and PTSD symptom clusters in active-duty police officers. Cogn Behav Ther. 2008;37:66–75. [PubMed]
14. APA. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 4. Washington, DC: American Psychiatric Association; 1994.
15. Southwick SM, Krystal JH, Morgan CA, et al. Abnormal noradrenergic function in posttraumatic stress disorder. Archives of general psychiatry. 1993;50:266–74. [PubMed]
16. Charney DS, Heninger GH, Breier A. Noradrenergic function in panic anxiety: effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry. 1984;41:751–763. [PubMed]
17. Roemer L, Orsillo SM, Barlow DH. Generalized anxiety disorder. In: Barlow DH, editor. Anxiety and its disorders: the nature and treatment of anxiety and panic. New York: The Guilford Press; 2002. pp. 477–515.
18. Borkovec TD, Shadick RN, Hopkins M. The nature of normal and pathological worry. In: Rappe RM, Barlow DH, editors. Chronic anxiety: Generalized anxiety disorder and mixed anxiety-depression. New York: Guilford Press; 1991. pp. 29–51.
19. Freeston MH, Ladouceur R, Rheaume J, Letarte H, Gagnon F, Thibodeau N. Self-report of obsessions and worry. Behav Res Ther. 1994;32:29–36. [PubMed]
20. Hoehn-Saric R, McLeod DR, Zimmerli WD. Somatic manifestations in women with generalized anxiety disorder. Arch Gen Psychiatry. 1989;46:1113–1119. [PubMed]
21. First MB, Spitzer RI, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-V (SCID) American Psychiatric Association; Washington, DC: 1995.
22. Blake DD, Weathers FW, Nagy LM, et al. The development of a Clinician-Administered PTSD Scale. J Trauma Stress. 1995;8:75–90. [PubMed]
23. Lissek S, Baas J, Pine DS, et al. Airpuff startle probes: an efficacious and less aversive altrenative to white-noise. Society for Psychophysiological Research; Santa Fe, NM. 2004. [PubMed]
24. Grillon C, Baas JMP, Pine DS, et al. The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle. Biol Psychiatry. 2006;60:760–766. [PubMed]
25. Grillon C, Levenson J, Pine DS. A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study. Neuropsychopharmacol. 2007;32:225–231. [PubMed]
26. Grillon C, Morgan CA, Davis M, Southwick SM. Effect of darkness on acoustic startle in Vietnam veterans with PTSD. American Journal of Psychiatry. 1998;155:812–817. [PubMed]
27. Pole N, Neylan TC, Best SR, Orr SP, Marmar CR. Fear-potentiated startle and posttraumatic stress symptoms in urban police officers. J Trauma Stress. 2003;16:471–9. [PubMed]
28. Lissek S, Pine DS, Grillon C. The strong situation: A potential impediment to studying the psychophysiology and pharmacology of anxiety disorders. Biological Psychology. 2006;72:265–270. [PubMed]
29. Grillon C. Greater sustained anxiety but not phasic fear in women compared to men. Emotion. 2008;8:410–413. [PMC free article] [PubMed]
30. Davidson JR, Kudler HS, Saunders WB, Smith RD. Symptom and comorbidity patterns in World War II and Vietnam veterans with posttraumatic stress disorder. Compr Psychiatry. 1990;31:162–70. [PubMed]
31. McFarlane AC, Papay P. Multiple diagnoses in posttraumatic stress disorder in the victims of a natural disaster. J Nerv Ment Dis. 1992;180:498–504. [PubMed]
32. Sierles FS, Chen JJ, McFarland RE, Taylor MA. Posttraumatic stress disorder and concurrent psychiatric illness: a preliminary report. Am J Psychiatry. 1983;140:1177–9. [PubMed]
33. Charney DS, Bremner DJ. The neurobiology of anxiety disorders. In: Charney DS, Nestler EJ, Bunney BS, editors. Neurobiology of Mental Illness. New York: Oxford University Press; 1999. pp. 494–517.
34. Craske MG. Anxiety disorders: psychological approaches to theory and treatments. Boulder, CO: Westview Press; 1999.
35. Borkovec TD, Inz J. The nature of worry in generalized anxiety disorder: a predominance of thought activity. Behav Res Ther. 1990;28:153–8. [PubMed]
36. Lissek S, Baas JM, Pine DS, et al. Sensation seeking and the aversive motivational system. Emotion. 2005;5:396–407. [PubMed]
37. Grillon C, Baas JP, Lissek S, Smith K, Milstein J. Anxious responses to predictable and unpredictable aversive events. Behav Neurosci. 2004;118:916–24. [PubMed]
38. Lissek S, Baas JMP, Pine DS, et al. Airpuff startle probes: an efficacious and less aversive alternative to white-noise. Biological Psychology. 2005;68:283–297. [PubMed]
39. Herry C, Bach DR, Esposito F, et al. Processing of temporal unpredictability in human and animal amygdala. J Neurosci. 2007;27:5958–66. [PubMed]
40. Kemp AH, Gray MA, Silberstein RB, Armstrong SM, Nathan PJ. Augmentation of serotonin enhances pleasant and suppresses unpleasant cortical electrophysiological responses to visual emotional stimuli in humans. Neuroimage. 2004;22:1084–96. [PubMed]
41. Harmer CJ, Rogers RD, Tunbridge E, Cowen PJ, Goodwin GM. Tryptophan depletion decreases the recognition of fear in female volunteers. Psychopharmacology. 2003;167:411–417. [PubMed]
42. Ohman A, Mineka S. Fears, phobias, and preparedness: toward an evolved module of fear and fear learning. Psychological Review. 2001;108:483–522. [PubMed]
43. Hamm AO, Weike AI. The neuropsychology of fear learning and fear regulation. Int J Psychophysiol. 2005;57:5–14. Epub 2005 Apr 21. [PubMed]
44. Phelps EA. Emotion and cognition: insights from studies of the human amygdala. Annu Rev Psychol. 2006;57:27–53. [PubMed]
45. Pole N, Neylan TC, Otte C, Henn-Hasse C, Metzler TJ, Marmar CR. Prospective prediction of posttraumatic stress disorder symptoms using fear potentiated auditory startle responses. Biol Psychiatry. in press. [PMC free article] [PubMed]
46. Grillon C, Dierker L, Merikangas K. Startle modulation in children at risk for anxiety disorders and/or alcoholism. Journal of American Academic Child Adolescent Psychiatry. 1997;36:925–932. [PubMed]
47. Grillon C, Dierker L, Merikangas KR. Fear-potentiated startle in adolescents offspring at risk for anxiety disorder. Biological Psychiatry. 1998;44:990–997. [PubMed]
48. Craske MG, Waters AM, Nazarian M, et al. Does Neuroticism in Adolescents Moderate Contextual and Explicit Threat Cue Modulation of the Startle Reflex? . Biol Psychiatry. in press. [PMC free article] [PubMed]
49. Hammack SE, Richey KJ, Watkins LR, Maier SF. Chemical lesion of the bed nucleus of the stria terminalis blocks the behavioral consequences of uncontrollable stress. Behav Neurosci. 2004;118:443–8. [PubMed]
50. Hasler G, Fromm S, Alvarez RP, Luckenbaugh DA, Drevets WC, Grillon C. Cerebral blood flow in immediate and sustained anxiety. J Neurosci. 2007;27:6313–6319. [PMC free article] [PubMed]
51. Alvarez RP, Biggs A, Chen G, Pine DS, Grillon C. Contextual fear conditioning in humans: cortical-hippocampal and amygdala contributions. J Neuroscience. 2008;28:6211–6219. [PMC free article] [PubMed]
52. Straube T, Mentzel HJ, Miltner WH. Waiting for spiders: Brain activation during anticipatory anxiety in spider phobics. Neuroimage. 2007;37:1427–36. [PubMed]
53. Mathew SJ, Price RB, Charney DS. Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics. American journal of medical genetics Part C, Seminars in medical genetics. 2008;148:89–98. [PubMed]
54. Risbrough VB, Stein MB. Role of corticotropin releasing factor in anxiety disorders: A translational research perspective. Hormones and Behavior. 2006 In Press, Corrected Proof. [PMC free article] [PubMed]
55. Baker DG, West SA, Nicholson WE, et al. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry. 1999;156:585–8. [PubMed]
56. Bremner JD, Licinio J, Darnell A, et al. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry. 1997;154:624–9. [PMC free article] [PubMed]
57. Kaviani H. Affective modulation of the startle response in depression: influence of the severity of depression, anhedonia, and anxiety. Journal of affective disorders. 2004;83:21–31. [PubMed]